SPONSOR
Ascentage Pharma Group Inc.
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)SLEPharmacokineticOlverembatinib
Ascentage Pharma Group Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), SLE, Pharmacokinetic.
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ascentage Pharma Group Inc.
How many clinical trials has Ascentage Pharma Group Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Ascentage Pharma Group Inc., of which 3 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), SLE. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ascentage Pharma Group Inc. research focus on?
Ascentage Pharma Group Inc. clinical trials span Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), SLE, Pharmacokinetic, Olverembatinib. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ascentage Pharma Group Inc. clinical trial?
To participate in a Ascentage Pharma Group Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ascentage Pharma Group Inc. trials with current recruitment status updated daily.
Clinical Trials by Ascentage Pharma Group Inc.
NCT04275518 Phase 1
Recruiting
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Acute Myeloid Leukemia (AML)
NCT06182969 Phase 1, Phase 2
Recruiting
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
SLE
NCT07282093 Phase 1
Recruiting
Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment
Pharmacokinetic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology